| The case for combination chemotherapy in the treatment of advanced ovarian cancer |
| RF Ozols |
|
JCO Nov 1 1985: 1445–1447.
[PDF]
|
 |
| Progress in treatment of advanced urothelial tract tumors |
| A Yagoda |
|
JCO Nov 1 1985: 1448–1450.
[PDF]
|
|
| Bone marrow transplantation as salvage therapy in advanced Hodgkin's disease: allogeneic or autologous |
| GP Canellos |
|
JCO Nov 1 1985: 1451–1454.
[PDF]
|
|
|
Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial |
| |
CJ Williams, GM Mead, FR Macbeth, J Thompson, JM Whitehouse, H MacDonald, VJ Harvey, ML Slevin, TA Lister, and JH Shepherd |
| |
JCO Nov 1 1985: 1455–1462.
[Abstract]
[PDF]
|
|
|
Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study |
| |
WG Harker, FJ Meyers, FS Freiha, JM Palmer, LD Shortliffe, JF Hannigan, KM McWhirter, and FM Torti |
| |
JCO Nov 1 1985: 1463–1470.
[Abstract]
[PDF]
|
|
|
VP-16 and cisplatin as first-line therapy for small-cell lung cancer |
| |
WK Evans, FA Shepherd, R Feld, D Osoba, P Dang, and G Deboer |
| |
JCO Nov 1 1985: 1471–1477.
[Abstract]
[PDF]
|
|
|
Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer |
| |
D Osoba, JJ Rusthoven, KA Turnbull, WK Evans, and FA Shepherd |
| |
JCO Nov 1 1985: 1478–1485.
[Abstract]
[PDF]
|
|
|
A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck |
| |
KS Dasmahapatra, P Citrin, GJ Hill, R Yee, MA Mohit-Tabatabai, and BF Rush, Jr |
| |
JCO Nov 1 1985: 1486–1489.
[Abstract]
[PDF]
|
|
|
Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease |
| |
FR Appelbaum, KM Sullivan, ED Thomas, CD Buckner, RA Clift, HJ Deeg, PE Neiman, JE Sanders, P Stewart, and R Storb |
| |
JCO Nov 1 1985: 1490–1494.
[Abstract]
[PDF]
|
|
|
Hodgkin's disease in childhood and adolescence: results of chemotherapy- radiotherapy in clinical stages IA-IIB |
| |
P Cramer and JM Andrieu |
| |
JCO Nov 1 1985: 1495–1502.
[Abstract]
[PDF]
|
|
|
Plasma cell acid phosphatase activity as prognostic factor in multiple myeloma: relationship to the thymidine-labeling index |
| |
M Boccadoro, A Gallamini, A Fruttero, P Gavarotti, V Redoglia, F Buffa, S Rua, and A Pileri |
| |
JCO Nov 1 1985: 1503–1507.
[Abstract]
[PDF]
|
|
|
Single agent vincristine by infusion in refractory multiple myeloma |
| |
DV Jackson, LD Case, EK Pope, DR White, CL Spurr, F Richards, 2d, JJ Stuart, HB Muss, MR Cooper, and WR Black |
| |
JCO Nov 1 1985: 1508–1512.
[Abstract]
[PDF]
|
|
|
Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group |
| |
G Reaman, P Zeltzer, WA Bleyer, B Amendola, C Level, H Sather, and D Hammond |
| |
JCO Nov 1 1985: 1513–1521.
[Abstract]
[PDF]
|
|
|
Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma |
| |
JR Quesada, A Rios, D Swanson, P Trown, and JU Gutterman |
| |
JCO Nov 1 1985: 1522–1528.
[Abstract]
[PDF]
|
|
|
Detorubicin--an active anthracycline in untreated metastatic melanoma |
| |
SP Chawla, SS Legha, and RS Benjamin |
| |
JCO Nov 1 1985: 1529–1534.
[Abstract]
[PDF]
|
|
|
4'Epidoxorubicin (epirubicin): activity in hepatocellular carcinoma |
| |
HS Hochster, MD Green, J Speyer, E Fazzini, R Blum, and FM Muggia |
| |
JCO Nov 1 1985: 1535–1540.
[Abstract]
[PDF]
|
|
|
The use of computed tomography of the spine to identify patients at high risk for epidural metastases |
| |
DE Weissman, M Gilbert, H Wang, and SA Grossman |
| |
JCO Nov 1 1985: 1541–1544.
[Abstract]
[PDF]
|
|
|
Heterogeneity in the specific activity and methotrexate sensitivity of dihydrofolate reductase from blast cells of acute myelogenous leukemia patients |
| |
S Dedhar, D Hartley, D Fitz-Gibbons, G Phillips, and JH Goldie |
| |
JCO Nov 1 1985: 1545–1552.
[Abstract]
[PDF]
|
|
|
Absence of major depressive disorder in female cancer patients |
| |
SB Lansky, MA List, CA Herrmann, EG Ets-Hokin, TK DasGupta, GD Wilbanks, and FR Hendrickson |
| |
JCO Nov 1 1985: 1553–1560.
[Abstract]
[PDF]
|
|
| Staging of small-cell lung cancer |
| SM Grunberg and TA Beaver |
|
JCO Nov 1 1985: 1561–1562.
[PDF]
|
|
| Deafness in intrathecal chemotherapy |
| GB Zulian, MS Aapro, A Michel, M Estade, C Baud, and R Hausler |
|
JCO Nov 1 1985: 1562–1563.
[PDF]
|
|
| Volume doubling approach to tumor measurement |
| CP Spears |
|
JCO Nov 1 1985: 1563a.
[PDF]
|
|
| Treatment of pathologic stages IA and IIA Hodgkin's disease |
| JJ Rusthoven |
|
JCO Nov 1 1985: 1563b–1564.
[PDF]
|
|
